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ABSTRACT
Background: Ocular infections caused by different groups of bacteria are important public health
problems worldwide. The situation is more worsened by the alarmingly increasing rate of antibiotic
resistance.
Objectives: The aim of this study was to assess the magnitude of the bacterial isolates, associated risk
factors and their antimicrobial susceptibility patterns isolated from patients with external ocular
infection at Borumeda Hospital, Northeast Ethiopia.
Methods: A cross-sectional study was conducted at Borumeda Hospital from February to May, 2014.
A systematic random sampling technique was used. Socio-demographic data and possible risk factors
were collected using structured questionnaire. External ocular specimens were collected according to
standard operational procedure. After collection, specimens were inoculated on MacConkey agar,
chocolate agar, blood agar and Mannitol Salt Agar. Presumptive bacterial colonies were isolated using
a series of biochemical tests based on their Gram reaction. Kirey Bauer disk diffusion method was used
to determine the antimicrobial susceptibility pattern of the isolates. Data were entered and analyzed
using SPSS version 20. Descriptive statistics and logistic regression analysis was used to determine
dependant and independent variable. P value <0.05 were considered as statistically significant to all
test.
Results: Among 160 patients, males were 94(58.8 %). The mean age of study participants was 55.11
years. Majority was 95(59.4%) culture positive for 89 (93.7%) Gram positive and 6(3.8%) was Gram
negative. Coagulase negative Staphylococci were the predominant isolate 51(31.9%) followed by S.
aureus 21(13.1%) and S. pneumoniae 10 (6.2%). Total multidrug resistance shows in 48 (50.5 %) of
the isolates. All Gram positive isolates were susceptible for vancomycin but 60(46.1%) of them showed
resistance against amoxicillin. Resistance for tetracycline, norfloxacylin, ceftriaxon and ciprofloxacin 4
(66.7 %) for each, was observed among Gram negative bacterial isolates. Multivariate analysis shows
the predisposing risk factor were no statistical significant association with dependant variable.
Conclusion: The prevalence of bacterial isolates in external ocular samples was high in the study area
and the dominant bacterial isolate was coagulase negative staphylococci. Amoxicillin resistance among
Gram positive bacterial isolates was exceptionally high. Although the number of Gram negative
bacterial isolates were small, drug resistance was comparatively significant. Therefore, identification of
ophthalmic bacterial etiological agent and conducting drug susceptibility test could reduce drug
resistance and increase cure rate during treatment.
Key words: Bacterial isolate, External ocular infections, Susceptibility pattern, Dessie
11. INTRODUCTION
1.1 Background and Statement of the Problem
Although relatively impermeable to microorganisms, infection within the eye can result
from trauma, ocular surgery or systemic disease. An infection in the eye does not respect
anatomical boundaries may occurred in any area and will spread to affect several different
anatomical structures but the conjunctiva, lid and cornea are more frequently infected
area (1). Infection of the eye can lead to loss or impairment of visual function with
clinical manifestations reported  in the world  are conjunctivitis, scleritis, keratitis,
blepharitis, canaliculitis, dacryocystitis; deeper infections such as orbital cellulitis,
preseptal cellulitis, necrotizing fascitis and intraocular infections such as uveitis,
endophthalmitis, panophthalmitis (2).
Ocular infection is an  important public health problem in the world and the morbidity
can vary from self limiting, trivial infection to sight threatening, caused by bacteria,
fungi, virus and protozoa (3).  Pathogenic microorganisms cause diseases to the eyes due
to their virulence and hosts reduced immunity. Just as the blind spot is neglected by the
brain, about 45 million people in the world who are blind are largely neglected by
medical science and technology, and by the caring professionals; of this 80% are
preventable. The situation in Ethiopia is similar with prevalence of blindness being about
1.5% and an estimated around 1.05 million blind people (4).
Bacteria are the major causative agents that frequently cause infections in the eye. The
common bacterial isolates associated with ocular infections include coagulase negative
Staphylocci (CoNS), Staphylococcus aureus, Streptococci spp, Gram negative cocco
bacilli and Gram negative bacilli (5, 6).
A serious bacterial eye infection that threatens the cornea and intraocular area is an
ophthalmic emergency that needs immediate treatment (7, 8). Management of bacterial
eye infection may involve treatment with broad spectrum antibiotics. This is most at times
before pathogen identification and antibiotic susceptibility tests are available. This
indiscriminate use of antibiotics has led to the development of resistance to many
commonly used antimicrobial medications. This development of antimicrobial resistance
are influenced by characteristics of pathogens, antibiotic prescribing practices include
overuse of antibiotics for systemic infection as well as overuse of topical antibiotics in the
eye, misuse of antibiotics for viral infections, extended duration of therapy and current
globalization and migration of populations (9, 10).
The knowledge of the infection, epidemiology and the antibiotic resistance patterns is
essential to guide optimal empiric treatment in critically ill patients. Antibacterial
susceptibility patterns and bacterial spectra vary geographically, highlighting the
importance of local surveillance data. In industrialized countries, these data are available
at regional, national and international levels; for instance as provided by the European
antimicrobial resistance surveillance system database (11, 12). However, current
surveillance data are scarce in Africa (11, 13). As there is a worldwide problem regarding
the emergence of bacterial resistance towards topical antimicrobial agents, which
increases the risk of treatment failure with potentially serious consequences leads to more
prevalent in Africa (14). Therefore, up to date information is essential for appropriate
antimicrobial therapy and management of ocular infections (15).
In the study area as well as in Ethiopia there is a scarcity of published data on the
spectrum of etiologic agents responsible for external ocular infections. Thus the aim of
this study was to assess the magnitude of the bacterial isolates, possible risk factor and
their antimicrobial susceptibility patterns isolated from patients with external ocular
infection at Borumeda Hospital, Northeast Ethiopia.
2. LITERATURE REVIEW
2.1 Prevalence and Etiology of Ocular Infection
The prevalence of external ocular infections that are caused by bacterial organisms varies
with the age of the patient, children and elderly patients are more susceptible to infection by
bacteria than young and middle-aged adult, (16) climate, and geographical variation: living in
rural or in city areas, in western, or in developing countries also spread differently (17).
Corneal diseases, specially infective keratitis, are a major cause of vision loss and blindness
second only to cataract (18, 19). In United Kingdom isolates including coagulase negative
Staphylococcus (CoNS) (30%), Pseudomonas aeruginosa (23%), Staphylococcus aureus
(14%), Enterobacteriaceae (14%), and Streptococci species (13%) were the main causative
etiology for bacterial keratitis (20). Study conducted in Paulo, Brazil, showed that 46-69% of
keritites were caused by bacteria pathogens and reported also that CoNS infection was
predominant (21).
Staphylococcus epidermidis is the main organism among the CoNS. It is part of the normal
flora of the skin and conjunctival sacs but may act as a pathogen causing fatal infections
which may have a significant incidence especially in the immune compromised host like
diabetes and acquired human immunodeficiency virus (AIDS) patients (22, 23).
Gram positive cocci: Streptococcus pneumoniae, Hemophilus influenza, Group A
Streptococcus were the main pathogens isolated form adult conjunctivitis (24).
Streptococcous viridans was associated with conjunctivitis in patients aged less than 1 year
(25). The most common causes of purulent conjunctivitis are Neisseria gonorrhea or
Staphylococcus species infection (26, 27). Contact lens wearers more likely develop Gram
negative conjunctivitis (28).
Bacteriologic and plasmid analysis of etiologic agents of conjunctivitis in Lagos, Nigeria
showed that Gram positive cocci isolate comprising Staphylococcus aureus and CoNS
species accounted for 50.3% of conjunctivitis cases, followed by Gram positive bacilli, Gram
negative bacilli and Gram negative cocci. Corynebacterium species was the most commonly
isolated Gram positive bacilli accounting for 16.1% of conjunctivitis cases. Pseudomonas
aeruginosa topped as the most commonly isolated Gram negative bacilli. Other Gram
negative bacilli in order of their isolations were Escherichia coli, Proteus species, Klebsiella
species, and Enterobacter aerogenes. From Gram negative cocci Moraxella species was the
only isolate. Further analysis of the complexity of infections showed that, polymicrobial
infections caused by two pathogens and three or more pathogens of conjunctivitis specimens
screened (29). In Uganda from conjunctival samples 45.8% cases were culture positive. The
most common organisms identified were CoNS and Staphylococcus aureus (30).
Even if there is extremely little literature about the prevalence or incidence of blepharitis,
ophthalmologists and optometrists surveyed that, it is commonly seen in 37% - 47% of their
patients. The etiology of blepharitis can be bacterial growth commonly caused by
Staphylococcus aureus and sebaceous gland, or meibomian glands malfunction (31).
Gram positive organisms: Streptococcus pneumoniae, Streptococcus pyogens,
Staphylococcus aurous, Streptococcus viridans were the most commonly isolated from
lacrimal abscess accounting for 62.6%. Hemophilus influenzae was the commonest Gram
negative isolate (32). A comparative study in India shows that proportions of Staphylococcus
aureus and Pseudomonas species are higher in causing acute dacryocystitis, (33), while the
proportion of CoNS is higher in chronic dacryocystitis in most of the country. But in
Malaysia and Ethiopia Streptococcus pneumoniae was the commonest identified Gram
positive organism (32,34).
Trachoma is the leading infectious cause of blindness worldwide. In 2003, World health
organization estimated that 84 million people were suffering from active trachoma, and 7.6
million were severely visually impaired or blind as a result of trachoma in the world (35). It
is caused by infection with Chlamydia trachomatis serovars A, B, Ba and C and is
characterized by inflammatory changes in the conjunctiva in children with subsequent
scarring, corneal opacity and blindness in adults. It is associated with poverty in
environments with inadequate sanitation, poor personal hygiene and poor water supply and is
now largely confined to developing countries, particularly in Africa and Asia (36).
In North India children Chlamydia trachomatis antigen positivity was varied between 22-28
% (37). In Ethiopia trachoma was found to be the leading cause of ocular morbidity among
children aged 1-9 years with prevalence of 33.7% - 40.14% (38, 39). The national
prevalence of trachomatous trichiasis is 3.1% with the highest prevalence in Amhara
regional state (5.2%). Over 9 million 1-9 year old children live with active trachoma, and 1.3
million people in 15 years and older have trachomatous trichiasis (39).
In general, the prevalence of bacteria caused external ocular infection in Ethiopia ranges
47.4% - 74.7% culture positive for different types of bacterial pathogens (40, 41). The most
common etiologic agent isolates were, Staphylococcus aureus, followed by Streptococcus
pnuemoniae, CoNS, Hemophilus influenza for Gram positive and Psuedomonas species for
Gram negative (40, 41); other study show Escherichia coli was the most predominant Gram
negative isolate (42),then Hemophilus aegyptius, Klebsiella pneumonia, Moraxella species,
Neisseria meningitides and others (40, 41).
2.2 Antimicrobial Susceptibility Pattern of Pathogens in Ocular   Infections
Local application of antibacterial compounds to the eyes may lead to bacterial resistance in
bacterial isolates from the eyes (43). Upon exposure to an antibacterial agent, bacteria with
these types of natural resistance mutations will be able to reproduce at a quicker rate than the
vulnerable bacteria. The problem of antimicrobial resistance shows no boundaries. But the
threat of antibiotic resistance is growing at an alarming pace more rapidly in developing
countries (44).
There are low resistance rates of Pseudomonas aeruginosa and Staphylococcus aureus to
ciprofloxacin in isolates from Australia. Isolates from the Indian subcontinent are more
commonly resistant to ciprofloxacin, with resistance rates of greater than 20 % reported. Data
from United States of America and Europe indicate that if the Staphylococcus aureus is a
methicillin resistant strain (MRSA) then resistance to ciprofloxacin increases, often to greater
than 80% of isolates. Resistance to gentamicin and cephalosporins is also generally low in
isolates from Australia (45).
In Brazil, between 1989 and 1992 no resistance to gentamicin was reported in Streptococcus
pneumonia. However, resistance to gentamicin was reportedly 42.3% in 1997 which
increased to 56% in the year 2000 (46). Similarly in South Florida MRSA showed significant
increase in 2007 ranged from 27.4 to 62.4% in prevalence. There were 2- and 3-fold
increases in resistance of Gram positive organisms to erythromycin and ciprofloxacin,
respectively. Gentamicin showed good sensitivity toward Gram positive pathogens (47).
Even if a very few available reports on vancomycin resistant Staphylococcus aureus ocular
infections; resistance to most groups of antibiotics is increasing with resultant decline in the
effectiveness of many commonly used topical antibiotics (48). Pseudomonas species tops the
list of challenging organisms to treat because of high prevalence of resistant strains.
Multidrug resistant (MDR) Pseudomonas aeruginosa have been reported from keratitis and
endophthalmitis patients leaving no choice other than to use piperacilin/tazobactum or
imipenem only for the treatment of such cases (45).
In Ethiopia, study conducted in  Jimma University Specialized Hospital on bacteriology of
ocular infections and antibiotic susceptibility patterns reported that majority of Gram positive
cocci were susceptible to ciprofloxacin and vancomycin and Gram negative isolates to
amikacin and ciprofloxacin (41). On the other hand, reports from Gondar showed that there is
high incidence of MDR problems in ocular pathogens that  ranges 77.3% of bacterial isolates
to the commonly prescribed antibiotics (42), leaving ophthalmologists with a very few
choices of drugs for the treatment of ocular infections (14).
3. SIGNIFICANCE OF THE STUDY
Vision impairments and blindness present substantial social and economic burdens on
individuals and society including significant suffering, disability, loss of productivity and
diminished quality of life for millions of people.
Clinical presentations alone are not diagnostic and a microbiological analysis with cultures
and antimicrobial sensitivities is mandatory for the selection of a specific antimicrobial
therapy. The clinical importance of external eye infections has been reported in some studies
in Ethiopia, with shortage of studies which have been supported by laboratory diagnosis and
the etiologic agents are scarcely known. Therefore treatment is empirically given with broad
spectrum antibiotics. This might results in a global increase in resistance among both Gram
positive and Gram negative bacteria to common antibiotics used to treat ophthalmic
infections and increase in morbidity, mortality and cost of health care.
So far there is no previous data or study showing etiology of microbial external ocular
infections and sensitivities pattern in the study area, this study attempted to identify the
magnitude of the etiologic agents and microbiological characteristics of microbial external
ocular infections and antimicrobial susceptibility patterns, which has an important public
health implication to gives a base line data for clinicians, health sector administrators,
concerned bodies and researchers.
4. OBJECTIVES
4.1. General Objective
The general objective was to assess the magnitude of bacterial profile, antimicrobial
susceptibility patterns and associated factors of bacterial profile isolated from patients with
external ocular infection at Borumeda Hospital, Northeast Ethiopia.
4.2. Specific Objectives
 To determine the prevalence of bacterial pathogens from patients with external ocular
infection.
 To determine the antimicrobial susceptibility patterns of bacterial isolates from
patients with external ocular infection.
 To identify possible factors associated with the bacterial external ocular infections.
5. MATERIALS AND METHODS
5.1 Study Area
The study was conducted at Borumeda Hospital in Dessie town. Dessie is capital city of
South Wollo Zone in Amhara regional state, North East Ethiopia, located 401 km far from
Addis Ababa. In this town there are 16 governmental health institutions (1 referral hospital, 1
primary hospital, 8 health centers and 6 health posts), and one regional health research
laboratory where culture and sensitivity tests were performed.  One of the primary hospitals
is Borumeda Hospital, where this study was conducted. Borumeda Hospital has 57000
patient flows per year, 110 beds for in patient and serving for one million people that are
found around the community.
5.2 Study Design and Period
A cross-sectional study was conducted from 15th of February to the 15th of May 2014.
5.3 Population
5.3.1 Source Population
 All patients with external ocular infection attending Borumeda Hospital.
5.3.2 Study Population
 All patients with external ocular infection attending Borumeda Hospital during the
study period.
5.4 Exclusion Criteria
 All Patients with external ocular infections, who had treatment with antibiotics in the
last 7 days.
 All Patients with external ocular infections: who performed ocular surgery within
7days.
 All Patients with external ocular infections: who developed severe ocular trauma
within 7 days.
 All Patients with external ocular infections who developed, keratitis, endophthalmitis
and allergic conjunctivitis.
5.5 Inclusion Criteria
 All patient who develops external ocular infections included in this study
5.6 Operational Definition
 External ocular infections: infections in the external eye structures include the
eyelids and surrounding tissues, conjunctiva, lacrimal apparatus, cornea, and anterior
chamber.
 Frequency of face washing: more frequent (washing of face two or more times per
day), frequent (washing of face once per day) and less frequent (washing of face
occasionally per a week) using water.
5.7 Variables
5.7.1 Dependent Variables
 Bacterial isolates
5.7.2 Independent Variables
 Age, sex, occupation, education,  residence
 Previous history of ocular trauma
 Frequency of face wash
 History of past ocular surgery
 Systemic disease
5.8 Sample Size and Sampling Technique
Sample Size
The sample size were determined using single population proportion formula= ( α/2) (1 − )
Where; n= the minimum sample size; Z= Standard normal distribution value at the 95% CI,
which is 1.96;  = level of significance; d= margin of error, taken as 5%; P= 75% prevalence
ocular infection taken from previous similar study conducted in Jimma university specialized
hospital.
=1.96x1.96 x 0.75(1-0.75)/0.05x0.05
= 288 people
From the above sample size calculation, n=288 were the sample size. However, the average
daily flow rate of external ocular infection in the eye clinic of the hospital is 5. The study
period were taking 3 months with 22 working days each month. Therefore there were a total
N= 330 patients visiting the clinic during the study period. Since expected numbers of
patients coming to eye clinic are less than 10,000, correction formula was used to get the
final sample size.
= n1 +
= 2881 + = 288 ÷ 2 = 144
When 10% non response rate was considered, the final sample size becomes 159.
Sampling Techniques
Systematic random sampling technique was used to select study subjects coming to the eye
clinic during the study period. Hence, to get 160 samples size, every k=N/n (330/160=) 2nd
client visiting the center was included by considering every 2nd client until the sample size
reached. The 1st client was selected by lottery method by writing number less than k value. A
patient who starts treatment with antibiotics in the previous day was excluding from the
study.
5.9 Data Collection and Laboratory Investigation
5.9.1 Socio-demographic data collection
After completed the consent form, Socio-demographic data and possible risk factor for
bacterial external ocular infection were collected by trained optometrist from each study
participants by using pre-tested structured questionnaire.
5.9.2 Specimen Collection and Laboratory Investigations
I. Specimen collection
After detailed ocular examinations using standard techniques external ocular specimens for
culture and smear were collected using moistened by saline, sterile cotton swab by gently
swabbing the eye, the lower conjuctival sac and lid margins. Purulent material in
dacryocystitis was collected by everted puncta then applying pressure over the lacrimal sac
area from more infected eye at outpatient department (OPD) of BH. Swabs of ocular samples
from patients were aseptically obtained from ocular infection sites before the eye were
cleaned with an antiseptic solution, topical anesthetic and antibiotic used. The swab was
immersed in 2ml of brain heart infusion and transported, using cold box, to Dessie Regional
Laboratory for investigation (49, 50).
II. Isolation and Identification of Bacteria
The collected specimens were inoculated on to MacConkey agar (Oxoid Ltd Basingstoke,
Hampshire, UK), Manitol Salt Agar(Oxoid Ltd) ,  Blood agar (Oxoid, LTD) incubated at
35°C-37°C for 24hrs on the other hand, the inoculated chocolate agar plates were incubated
in addition of 5% CO2 atmosphere. All the plates were initially examined for growth after
24 hours; and cultures with no growth were incubated for further 48 hours. After obtaining
pure colonies, further identification were conducted by using the standard biochemical tests
after differentiating using Gram’s staining (49). Gram negative rods were identified by
performing a series of biochemical tests which include triple sugar iron agar, indole, Simon’s
citrate agar, lysine iron agar, urea, mannitol and motility. Gram positive cocci were identified
based on their Gram reaction, catalase, coagulase, bacitracin and optochin test results (49).
III. Antimicrobial susceptibility testing
The antimicrobial susceptibility test of the isolates was performed according to the national
committee for clinical laboratory standards (NCCLS) method using Kibry-Bauer disk
diffusion test on Muller-Hinton agar. Biochemically confirmed isolates were suspended in a
nutrient broth and incubated for 30 minutes to make it comparable with 0.5% McFarland
standard. After incubation a sterile cotton swab was dipped in to the suspension and bacteria
were inoculated on to the Muller-Hinton agar (Oxoid CM0337 Basingstoke, England).
The standard antibiotic disks used from Oxoid (UK) were gentamicin 30 μg, ampicillin 30
μg, amoxicillin 30 μg, and cefoxitine 25 μg, penicillin 10U, vancomycin 30 μg for Gram
positive and gentamicin 30 μg ciprofloxacin 5μg, tetracycline 30μg, doxycycline 30μg, were
used for Gram negative bacteria. Antibiotic discs were placed by using disc dispenser on the
agar surface in such a way that each disk were  placed at least 24 mm away from each other
to avoid the overlapping zone of inhibition. After the disk is placed, the plates were allowed
to stand for 15 minutes for the antibiotic to dissolve in the media and the plate was incubated
for 24 hrs at 35C. Results were interpreted as sensitive, intermediate and resistant after
measuring the zone of inhibition and comparing with the standards (49).
5.9.3 Quality Control
The questionnaire was prepared in English and translated to Amharic and then back
translated to English for consistency. The questionnaire was pretested on ten study subjects
in Dessie Referal Hospital eye clinic and amendments were made.
All specimens were collected according to the standard operating procedure. The sterility of
culture media was ensured by incubating 5% of each batch of the prepared media at 37oc for
24 hours. Performances of all prepared media were also checked by inoculating known
bacterial strains such as E. coli (ATCC 25922), S. aureus (ATCC 25923) and P. aeruginosa
(ATCC 27853) and Neisseria gonorrheae (ATCC 49226) were employed as strains of quality
control for the antimicrobial susceptibility test. After collection, all data including laboratory
results were checked for completeness by principal investigator each day and essential
feedback were sent to data collectors. To ensure the accuracy of data, double data entry
methods were used (49).
5.9.4 Data Analysais
Data were entered and analyzed using SPSS version 20. Descriptive statistics and logistic
regression with bivariate and multivariate analysis were used to determine the association
between dependant and independent variable with 95% confidence interval, P value <0.05
was considered as statistically significant to all test and results were presented by tables and
figures.
5.10 Ethical Consideration
Ethical clearance was obtained from the Ethical Committee of School of Biomedical and
Laboratory Sciences, College of Medicine and Health sciences, University of Gondar.
Official permission and written informed consent was obtained from Borumeda Hospital, and
study participants respectively. The consent of children was obtained from their family or
guardian. All the information obtained from study participants were kept confidential. The
laboratory result from the study participant was contacted to their doctors for appropriate
treatment.
6. RESULTS
6.1 General characteristics of study participants
6.1.1 Socio-demographic characteristics
A total of 160 patients, majority were males 94 (58.8%), participated in this study. The mean
(±SD) age of study participants was 55.11(± 17.85) years. In terms of educational status,
most of the study participants were illiterate 132 (84.5%), majority 120 (75 %) were rural
dwellers and their occupation was farmer 106 (66.3%) (Table1).
6.1.2 Clinical characteristics
In this study, 69(43.1%) patients were suffering from conjunctivitis followed by blepharitis
47(29.4%).  The dominant type of ocular infection among male patients (n=94) was
conjunctivitis 41(43.6%) were as in female patients (n=66) a higher cases of dacryocystitis
7(10.6%) was observed (Figure 2).
Figure 1-Clinical Features of External Ocular Infection in relation to Sex of Study Subjects at
BH, Dessie, from February to May, 2014.
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Table 1-Socio-demographic Characteristics of Patients with External Ocular Infections at BH
from February to May, 2014.
Socio-demographic Characteristics (Frequency) n (%)
Age in years
≤ 45 44 27.5
46-55 30 18.8
>56 86 53.8
Residence
Rural 120 75.0
Urban 40 25.0
Sex
Male 94 58.8
Female 66 41.3
Occupation
Employed 14 8.8
Farmer 106 66.3
Merchant 11 6.9
Hose wife 14 8.8
Other* 15 9.4
Educational status
82.5
16.3
1.3
Unable to write and read 132
Write and read only 26
primary school  & above 2
Others *-student, daily laborer, unemployed, driver
6.2 Prevalence of the Bacterial Isolate
Among 160 ocular specimens subjected to cultures, 95(59.4%) were culture positive for
different bacterial species. From these, 89(55.6%) had single species of bacteria and the
remaining, 6 (4.4%) had two isolates. Majority (93.%) of the isolates were Gram Positive
bacteria; coagulase negative Staphylococci being the most frequent isolate 51(31.9%)
followed by S. aureus 21(13.1%) and S.pneumoniae 10(6.2%). E. coli 1(0.6%), P.
aeuroginosa 1(0.6%), K. pneumoniae 1(0.6%), P. mirabilis 2(1.2%), Salmonella spp.
1(0.6%), and Entrobacter spp, 1(0.6%) comprised the negative isolates (Table 2).
Table 2-Bacterial Growth Pattern of Ocular Specimens from Study Participants at BH,
Dessie from February to May, 2014.
Bacterial isolate Frequency n (%)
CoNS 51 31.9
S. areus 21 13.1
S. pneumonia 10 6.2
Viridian streptococci 3 1.9
S.pyogens 6 3.8
S. agalactiae 1 0.6
Enterococci spp 1 0.6
E.coli 1 0.6
p. aerogenosa 1 0.6
k. pneumonia 1 0.6
Proteus mirabilis. 2 1.2
Salmonella spp. 1 0.6
Enterobacter spp. 1 0.6
Total 95 100
6. 3 Association of Risk Factors and Bacterial Isolates
In this study, occupation, residence, education, frequency of face washing and the occurrence
of systemic disease were used as possible risk and predisposing factors for ocular infection.
The risk of acquiring in those patients with ≥ 56 years ages was 1.96 times more likely than
those with ≤55 years age (OR=1.96, CI: 0.8-4.3). Patient that were less frequently washing
their face for the bacterial ocular infection were 1.8 times more likely to be infected than the
frequently washing (OR=: 1.8, 95% CI: 0.76-4.2). The risk of acquiring bacterial ocular
infection in patient residence in rural was 1.4 times more likely than those in urban (OR=1.4,
CI: 0.7-2.98).
Age, sex, residence, occupation, educational status, frequency of face wash, history of ocular
trauma, past ocular surgery and systemic disease did not significantly (P>0.05) influence the
occurrences of bacterial ocular infection in the current study through multivariate regression
analysis. On the other hand, age and frequency of face washing were found to be
significantly (P<0.05) associated with the occurrence of the bacterial ocular infection through
bivariate logistic regression analysis (Table 3).
Table 3-Multivariate and bivariate logistic regression analysis of the identified predisposing
risk factors and bacterial isolates from external ocular samples at BH, Dessie, Ethiopia from
February to May, 2014.
Predisposing risk factors Bacterial isolate COR*(95% CI) P
value
AOR*(95% CI)
Yes No
n(%) n (%)
Age in years
≤45 20(45.5) 24(54.5) 1
46-55 17(56.7) 13(43.3) 1.57(0.62-3.996) 0.3 1.3(0.5-3.3)
≥ 56 58(67.4) 28(32.6) 2.49(1.2-5.2) 0.02 1.96(0.8-4.3)
Sex
Male 57(60.6) 37(39.4) 1.14(.599-2.153) 0.7 -
Female 38(57.6 ) 28(42.4) 1
Residence
Urban 20(50) 20(50) 1
Rural 45(37.5) 75(62.5) 1.7(.8-3.4) 0.2 1.4(0.7-2.98)
Occupation
Employed 10(71.4) 4(28.6) 1
Farmer 65(61.3) 41(38.7) 0.6(.9-2.2) 0.5 1.3(0.3-5.7)
House wife 5(35.7) 9(64.3) 0.2(.045-1.094) 0.06 0.5(0.2-1.5)
Other 15(57.7) 11(42.3) .545(.135-2.2) 0.4 0.2(0.05-1.06)
Education
Not write and read 80(60.6) 52(39.4) 1.5(0.09-25) 0.76 -
write and read only 14(53.8) 12(46.2) 1.2(0.07-21) 0.9
Primary school  & above 1(50) 1(50) 1
Frequency of face washing
More  frequent 17(54.8) 14(45.2) 1 1
Frequent 16(41) 23(59) .57(.22-1.5) 0.3 .7(.19-1.9)
Less frequent 62(68.9) 28(31.1) 1.82(.79-4.2) 0.2 1.8(.76-4.2)
History of ocular trauma
Yes 9(64.3) 5(35.7) 1.26(.401-3.9) 0.7 -
No 86(58.9) 60(41.1) 1
Past ocular surgery
Yes 6(54.5) 5(45.5) 0.8(2.36-2.78) 0.7 -
No 89(59.9) 60(40.3) 1
Systemic disease
Yes 11(52.4) 10(47.6) 1.4(.55-3.5) 0.5 -
No 84(60.4) 55(39.6) 1
*AOR=adjusted odds ratio, *COR=crude odds ratio
6.4 Antimicrobial Susceptibility Testing
In this study majority of Gram negative isolates were resistant to most of the antibiotics
tested than the Gram positives. The rates of susceptibility of Gram positives range from
46.1% - 100 %. Among the Gram positives, 83(93.3 %) and 89(100 %) of the isolates were
sensitive to cefoxitine and vancomycine respectively. However, more than half of Gram
positives showed resistance against amoxicillin 48(53.9%) and 31(34.7%) were ampicyline
resistant. Resistance to cefoxitine was observed among 4 isolates (7.8%) of the CoNS.
Viridian streptococci, S. agalactae and entrococci isolates were 100% sensitive to all the
drugs tested (Table 4).
Rates of susceptibility of Gram negatives range from 66.7 % - 83.3 %. The drug
susceptibility patterns of the Gram negatives bacterial isolates showed that 5 out of 6 (83.3%)
were sensitive to gentamycine. However, majority of Gram negative bacteria isolates 4
(66.7%) were resistance to tetracycline, norfloxacyline, ceftriaxone, and ciprofloxacin each.
(Table 5).
Table 4-Antimicrobial Sensitivity Pattern of Gram Positive Bacterial Isolates from External Ocular samples at BH, Dessie,
Ethiopia from February to May, 2014.
CoNS*= Coagulase Negative Staphylococcus, S= sensitive, I= Intermediate, R= Resistance
Amp- Ampicyline, CRO- Ceftriaxone, FOX- cefoxitine ,  CIP- Ciprofloxacin, DA- Clindamycine, AMP - ampicyline, AML-
amoxicillin ,PE- penicillin, VAN- Vancomycin
Organisms
isolated(n=88)
Antibiotics tested
VAN PE DO AMP AML DA FOX CIP CRO
S.pneumoniae S 10(100%) 6(60%) 8(80%) 7(70%) 4(40%) 9(90%) 9(90%) 8(80%) 10(100%)
I 0 0 0 0 0 0 0 0 0
R 0 4(40%) 2(20%) 3(30%) 6(60%) 1(10%) 1(10%) 2(20%) 0
CoNS S 51(100%) 37(72.5%) 37(72.5%) 37(72.5%) 26(51%) 47(92.2%) 47(92.2%) 47(92.2%) 45(88.3%)
I 0 1(2%) 0 5(9.8%) 0 0
R 14(27.5%) 13(25.5%) 14(27.5%) 20(39.2%) 4(7.8%) 4(7.8%) 4(7.8%) 6(11.8%)
S.aureus S 21(100%) 14(66.7%) 12(57.1%) 11(52.4%) 7(33.3%) 17(81%) 20(95.2%) 19(90.5%) 20(95.2%)
I 0 0 2(9.5%) 0 1(4.8%) 1(.6%) 0
R 0 7(33.3%) 7(33.3%) 10(47.6%) 13(61.9%) 3(14.3%) 1(4.8%) 2(9.5%) 1(4.8%)
S. pyogen S 6(100%) 4(66.7%) 5(83.3%) 2(33.3%) 2(33.3%) 5(83.3%) 6(100%) 6(100%) 5(83.3%)
I 0 0 0 0 0 1(16.7%) 0 0 0
R 0 2(33.3%) 1(16.7%) 4(66.7%) 4(66.7%) 0 0 0 1(16.7%)
Enterococci
spp.
S 1(100%) 1(100%) 1(100%) 1(100%) 1(100%) 1(100%) 1(100%) 1(100%) 1(100%)
I 0 0 0 0 0 0 0 0 0
R 0 0 0 0 0 0 0 0 0
Table 5-Antimicrobial Sensitivity Pattern of Gram Negative Bacterial Isolates from External Ocular samples at BH, Dessie,
Ethiopia from February to May, 2014.
CIP- ciprofloxacyline   , CRO- ceftriaxone, NOR-norfloxacyline ,  CIP- Ciprofloxacin, GS- Gentamycin, TE- Tetracyclin
S= sensitive, I= Intermediate, R= Resistance
Organism(n=6) Sensitivity Antibiotic tested
CRO NOR TE GS CIP
P. aerogenosa S 1(100 %) 1(100%) 1(100%) 1(100%) 1(100%)
I 0 0 0 0 0
R 0 0 0 0 0
P. mirabilis S 2(100%) 2(100%) 1(50%) 2(100%) 2(1000%)
I 0 0 0 0 0
R 0 0 1(50%) 0 0
E. coli S 1(100%) 0 0 0 0
I 0 0 0 0 0
R 0 1(100%) 1(100%) 1(100%) 1(100%)
Salmonella spp. S 1(100%) 1(100%) 1(100%) 1(100%) 1(100%)
I 0 0 0 0 0
R 0 0 0 0 0
Enterobacter spp. S 0 0 1(100%) 1(100%) 0
I 0 0 0 0 0
R 1(100%) 1(100%) 0 0 1(100%)
k.pneumoniae S 0 0 0 1(100%) 0
I 0 0 0 0 0
R 1(100%) 1(100%) 1(100%) 0 1(100%)
6.4 Multi-drug Resistance Pattern of Bacterial Isolates from External Ocular Samples
Among the total bacterial isolates (n = 95) multi-drug resistance (MDR = resistance in ≥2
drugs) were recorded in 48 (50.5 %). In this study S. aureus accounts the highest drug
resistance prevalence of 12(57%) then CoNS 28(54.9%).
Table 6-Multi-drug resistance pattern of isolates from external ocular spacemen’s, at BH,
from February to May, 2014.
R1= resistant to one antimicrobial R4= resistant to four antimicrobial
R2= resistant to two antimicrobial R≥5= resistant to greater or equals to five antimicrobial
R3= resistant to three antimicrobial
Bacterial
isolates
n R1 R2 R3 R4 R5 Total
S. aureus 21 0 4(19.4%) 2(9.5%) 4(19.4%) 2(9.5%) 12(57%)
CoNS 51 5(9.8 %) 8(15.6%) 8(15.6%) 4(7.8%) 3(5.8%) 28(54.9%)
S. pneumoniae 10 0 2(20%) 1(10%) 2(20%) 1(10%) 6(60%)
S. pyogenes 6 0 1(16.6%) 2(33.3%) 1(16.6%) 0 4(66.6%)
E. coli 1 0 0 1(100%) 0 0 1(100%)
Enterobacter
spp.
1 0 0 1(100%) 0 0 1(100%)
k. pneumoniae 1 0 0 1(100%) 0 0 1(100%)
Total 5(5%) 15(15.8%) 16(16.8%) 11(11.6%) 6(6.3%) 53(58.3%)
7. DISCUSSIONS
The organisms that cause ocular infection are generally exogenous. However in certain
circumstances they gain accesses to inter the eye and cause infection. In this study,
prevalence of bacterial eye infection was 95(59.4%) of 160 ocular specimens for different
bacterial species which are comparable with other studies done in Gondar 60.8% (51) and
54.2 % (40), Nigeria 50.3% (29) and in India 58.8% (17). However, the isolation rate was
higher in Jimma 74.7 % (41), India 68.9% (52) and lower in Addis Ababa 47% (40). This
may be due to difference in local climate, sample size, inclusion and exclusion criteria.
Gram positive bacteria were the dominant isolate accounting for 55.6% prevalence. This is
also supported by other studies conducted in Ethiopia (42, 51), Nigeria (29), India (17) and
other parts of the world had shows similar results inferring Gram positive cocci as a primary
cause of bacterial external ocular infection.
Coagulase negative Staphylococcus was the most predominant pathogen with over all
isolation rates of 51(31.9%). Comparable findings in India (5), Uganda (30) and Ethiopia
(51) have been showed CoNS was the most predominant isolated pathogen. However, most
of study shows that S. aureus was the predominant isolate (6, 29, 41, 42). The high
pathogenicity of S. aureus is attributed to their being able to multiply and spread widely in
tissues through their production of many extra cellular substances like coagulase which
deposits fibrin on the surface of the microorganism altering their ingestion by phagocyte
cells; alpha toxin (hemolysin) which lyse erythrocyte and damage platelets (49).
In Malaysia and Ethiopia Streptococcus pneumoniae was the commonest identified Gram
positive organism in external ocular infection (32,34). We can understand from the above
data at different settings that different types of Gram positive cocci bacteria could be
particularly significant in causing ophthalmic infections. This variation may be due to
differences in the environment, the standard of personal hygiene, age and site of infection.
The prevalence of Gram negative bacteria as causative agents of ophthalmic disease can be
graded lower as only 6 (3.8%) were isolated. This was supported by study reports from
Jimma (41), Southwestern parts of Ethiopia and in some African countries such as Nigeria
(6). The low prevalence of Gram negative enteric bacteria could be due to effective personal
hygiene as the most important mode of transmission for enteric pathogens is fecal-oral
contamination of the eye. During data collection, we noticed that health extension workers
deliver health education about latrine usage and west disposal in the study area and the main
cause for Gram negative ocular infection is contact lens wearer (28). No contact lens wearer
was observed in the study area.
In the present study external ocular infections were predominantly seen in male sex due to
their outdoor activities. This is similar to study in Gondar and Jimma (41, 51). The inter-age
group variation in the three age groups was statistically not significant but, data showed that
patients with ≥ 56 years of age has a higher frequency of 86(53.8%) of bacterial isolates.
CoNS comprise higher prevalance 33(64.7%) than less age group. Similar study shows that
Staphylococcus epidermidis and Staphylococcus aureus isolated greater percentage from the
elders than children and adults (53). Staphylococcus epidermidis and Staphylococcus aureus
is normal flora that parasitized conjunctival sac which is changing dynamically through our
life time because of its long term exposure to the environment. Diseases will be caused when
alteration of normal flora occurred. This alteration may be due to elders having a lower
resistance from decreased immune functions, reduction of lacrimal secretions, reductions in
some kinds of antibodies, complement proteins and enzymes in tears (54).
Study done by Long et al shows that relationship between positive culture of CoNS and
different variables such as sex, age, composition of injury causing object and metallic injury
(p < 0.01) were both significantly associated (56). Multivariate analysis of this study shows
that bacterial isolate has no significant association with possible risk factor. The main reason
may be since it is a hospital based study result may be accidental on the other hand sample
size was small.
Resistance and sensitivity in vitro testing results clinician to provide information that allows
making rationale based decision in choosing an initial regimen for treatment of ocular
pathogens (13).
Based on results from susceptibility testing in this study, Gram positive cocci were 100%
sensitive to vancomycine. However most of ampicyline and amoxicillin antibiotics were
shows resistance. Similar findings have been reported in Gondar (51). This is because
Vancomycin is basically a glycopeptides; which inhibits cell wall mucopeptide synthesis in
early stages and it exhibited greatest potency against ocular Gram positive isolates (44).
Reduced efficacy of ampicyline and amoxicillin could possibly due to the frequent usage of
the drugs by the patients as these antibiotics are commonly used by many patients with and
with no prescription. This is evidenced by the screeched establishment of drug venders which
potentially sell antibiotics even with no direct order from the respective physician.
Most of Gram negative isolates were sensitive to gentamicin 5(83.3 %). However, majority
of Gram negative bacteria isolates were resistance to tetracycline, norfloxacyline, ceftriaxon,
ciprofloxacin 4(66.7 %). This is in agreement with similar study (55). Pseudomonas species
tops the list of challenging organisms to treat because of high prevalence of resistant strains
(45). In contrary in this study 100% sensitive to all antibiotics.
Resistance strain is increase in ocular bacterial isolate might be due to an irrational and
unnecessary use of antimicrobial agents including the widespread use of systemic antibiotics
which can result in the emergence of bacterial strains that show multidrug resistance. Other
contributing factors may include improper dosage regimen during administration. This also
includes because of difficulty of administration drops antibiotics in day time use in adult
populations (16).
In Ethiopia, it is in common practice that antimicrobials can be purchased without
prescription, which leads to misuse of antibiotics. This may contribute to the emergence and
spread of antimicrobial resistance (40, 41, 42). Other factors may include availability of the
suboptimal quality or substandard antimicrobial drugs, increased usage of a particular
antimicrobial agent, poor sanitation, contaminated food and cross-contamination from
humans or animals (6, 10).
8. LIMITATIONS OF THE STUDY
The aim of our study was on bacterial causative agents of external ocular infection, however,
due to limitations anaerobic bacteria, Chlamydia trachomatis were not isolated. Some of the
bacterial isolates were reported as CoNS which is not specific. Associated factor was not
assessed for antimicrobial susceptibility test and sample size was too small.
9. CONCLUSIONS
This study shows that bacterial ocular infection is the major problem in Borumeda Hospital.
The most commonly isolated bacteria were Gram positive organisms than Gram negatives.
Coagulase negative Staphylococci were the predominant isolate followed by S. aureus and S.
pneumoniae. Most of the Gram positive isolates were sensitive to vancomycin and cefoxitine,
whereas Gram negative organisms were sensitive to gentamycine. However, a significant
number of Gram negative bacteria isolates were resistance to tetracycline, norfloxacyline,
ceftriaxone, ciprofloxacin and more than half of Gram positives showed resistance to
amoxicillin.
10. RECOMMENDATIONS
Focusing attention on the present study results, the following recommendations are
forwarded
 Science bacteria caused eye infection was the dominant problem observed in this
study. Proper laboratory based diagnosis should be done to identify the etiology of the
disease and antimicrobial susceptibility testing periodically to follow the change of
pattern of the isolates and sensitivity over time.
 For Physicians
 Decrease empirical therapy by, and advise isolation of causative
bacterial agents, and subsequent susceptibility testing.
 Most Sensitive drugs to bacterial isolate like vancomycin should be
reserved for treating infections that are resistant to other anti-
staphylococcal antibiotics or in cases of severe corneal infections.
 For individual
 Avoid purchasing antimicrobials without prescription
 Protect personal hygiene particularly face washing for which Strengthen the
provision of contentious health education might be required from Borumeda
Hospital.
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12. ANNEXES
Annex I Questionnaire (English Version)
Questionnaire for investigation of Bacterial Profile of external ocular Infections and their
Antimicrobial Susceptibility Patterns in Patients Attending Borumeda Hospital: Northeast
Ethiopia.
Questionnaire code number
Card number
Date of data collection
Diagnosis
Socio-demographic information
Instruction: Read the questions audible and circle the appropriate response; for question 1,
enter age in years.
SN QUESTIONS CODING CATEGORIES
1 Age( in years)
2 Sex 1.Male
2.Female
3 Education status 1. Civil servant
2. Farmer
3.Merchant
4.House wife
5. Daily laborer
6. Other (specify)_______
4 Residence? 1. Urban
2. Rural
5 Occupation? 1. Civil servant
2. Farmer
3.Merchant
4.House wife
5. Daily laborer
6. Other (specify)_______
6. Type of ocular infection? 1. Blepharitis
2. Conjunctivitis
3. Belpharo- Conjunctivitis
4. Hordeolum
5. Dacryocystitis
6. Other infection, specify
7 Was antibiotic prophylaxis
given?
1.Yes
2.No
8 Have you get eye trauma? 1.Yes
2.No
9 Do you wear contact leans? 1.Yes
2.No
10 Do you perform eye surgery? 1.Yes
2.No
11 Availability of chlorinated
water source?
1.YES
2.NO
12 Frequency of face wash in one
day
1. more frequent
2. frequent
3. less frequent
13 Have you ever had a blood test
for diabetic mellitus?
1.Yes
2. No
14 If yes, what was the result? 1. I am known diabetic patient
2. I am normal
15 Do you have Systemic
infection?
1. Yes
2. No
THANK YOU!!
Annex -II Laboratory Data Collection Form
1. Code no____________
2. Age   ______Sex ________           Date_____
3. Types of specimen         swab of ulcer, purulent specimen, vitreous aspiration & corneal
scrapings
4. Media
used_________________________________________________________________
5. Organism isolated
___________________________________________________________________________
___________________________________________________________________________
______
Culture and biochemical tests identification
___________________________________________________________________________
__________________________
___________________________________________________________________________
__________________________________________________________
7. Gram stain from specimen__________________________________
8. Result of Gram stain from culture_________________________________
9. Antimicrobial test
Sensitive to __________________________________________
Intermediate to_________________________________________
Resistance to__________________________________________
Comments
Name of principal investigator   ___________________________
Signature ____________________   Date____________________
Annex- III Procedure External ocular infections
Culture
Biochemical
GNB
M/I/U GPC
KIA Bacitracin
CHO                                                                                                                      Catalase
Citrate Coagulase
Mannitol fermentation Optochin
Ox
Drug susceptibility test
Figure 2 Flow Chart for Laboratory ProcedurTerms: GPB=Gram positive bacilli, GNB= Gram negative bacilli,
M/I/U= Motility/Indole/Urea, Ox= Oxidase test, CHO= Carbohydrate Utilization tests, BA= Blood agar, CA= Chocolate agar,
MSA= Manitol salt agar, MAC= MacConkey agar, BHI=Brain Heart Infusion transport mediu
A. To prepare the culture media
MSA
Gs
Blepharitis, Conjunctivitis
Dacrocystites
Swabs
BHI
Gs
CA BA MAC
1. Read the label on a bottle of dehydrated agar media. It specifies the amount of
dehydrated powder required to make 1 liter (1,000 ml) of medium. Calculate the
amount needed for 1/2 liter and weigh out this quantity.
2. Place 500 ml of distilled water in an Erlenmeyer flask. Add the weighed, dehydrated
agar while stirring with a glass rod to prevent lumping.
3. Set the flask on a tripod over an asbestos mat.
4. When the agar mixture was completely dissolved, remove the flask from the flame or
hot plate, close it with the cotton plug or cap, and it has to be sterilized in the
autoclave.
5. When the flask of sterilized agar was returned to you, allow it to cool to about 50°C
(the agar should be warm and melted, but not too hot to handle in its flask). Remove
the plug or cap with the little finger of your right hand and continue to hold it until
you are sure it won’t have to be returned to the flask. Quickly pour the melted, sterile
agar into a series of petri dishes. The petri dish tops are lifted with the left hand and
the bottoms are filled to about one-third capacity with melted agar.
6. Replace each petri dish top as the plate was poured. When the plates are cool (agar
solidified), invert them to prevent condensing moisture from accumulating on the
agar surfaces.
7. Place inverted agar plates in the 35°C incubator. They should be incubated for at least
24 hours to ensure they are sterile (free of contaminating bacteria) before you use.
B. Collection and processing of specimen from ocular infection
I. The specimens were collected by an experienced optometrist. Special care was taken
to avoid contaminating the specimen with commensal organisms from the skin by
swiping normal saline moistened cotton.
II. With sterile cotton tipped applicator stick moistened with normal saline collect
sample from   the infected site by rubbed over the lower conjunctival sac from medial
to lateral side and back again, swabbing the lid margins in cases of blepharitis.
Purulent material in dacryocystitis was collected by everte dpuncta then applying
pressure over the lacrimal sac area.
III. Label the sample with the patient code number
IV. Inoculate in to checolate, MacConkey and blood agar manitol salt agar aseptically
V. Incubate the plate aerobically at 35-37 ℃for 18-24 hours.
VI. Examine and report the culture; look for colony characteristics and perform
biochemical test.
VII. Determine drug susceptibility pattern of the isolated organism
C. Gram stain procedures
1. Prepare a thin smear of the culture or specimen will be observed.
2. Allow to air-dry and fix the smear.
3. Cover the fixed smear with crystal violet for 1 min.
4. Rinse with clean water and tip off all the water.
5. Cover the smear with Lugol’s iodine for 1 min.
6. Wash off the iodine with clean water.
7. Add acetone-alcohol for 30 sec.
8. Wash the smear immediately with clean water.
9. Cover the smear with saffranin for 1-2 minutes.
10. Rinse with clean water.
11. Wipe the back of the slide and place in a draining rack for the smear to air-dry.
12. Examine microscopically, first with the 40x objective and then with the oil immersion
objective for white cells, bacteria and other structures.
- Gram- positive bacteria -------------Dark purple
- Gram- negative bacteria ------------Pale to dark red.
D. Biochemical testing procedures
Identification of Gram positive bacteria: Gram positive cocci were identified based on
their
Gram reaction, catalase and coagulase test results.
Catalase test: This test was used to differentiate staphylococci (positive) from streptococci
(negative)
Procedure
A. Pour 2-3 ml of 3% hydrogen peroxide to a test tube
B. Using a sterile wooden stick take the test organism and immerse into the hydrogen
peroxide solution
C. Look for immediate bubbling
Interpretation:
 Active bubbling…………………………….. positive test
 No release of bubbles…………………………negative test
Coagulase test: This test was used to differentiate Staphylococcus aureus from other
Staphylococcus species.
Procedure
I. Place a drop of physiological saline on two separate slides
II. Emulsify the test organism in each of the drop to make thick suspension
III. Add one drop of plasma to one of the suspensions and mix gently. Look for clumping
of the organism within 10 seconds
Interpretation:
Clumping within 10 seconds ------------------S.aureus
No clumping within 10 seconds -------------other staphylococcus species
Identification of Gram negative bacteria: was based on their test result with a series of
biochemical tests.
Procedure
1. Prepare a suspension of the test organism with nutrient broth 3-4 colony of test
organism in 5 ml nutrient broth.
2. A loop full of the bacterial suspension was inoculated in to indole, citrate agar, triple
sugar iron agar, lysine decarboxylase agar, manitol, urea agar and motility medium.
3. Incubate at 35-37 Oc for 18-24 hours.
4. Look for color change (turbidity for motility) of the medium
5. Identify the test organism by considering the result of the six biochemical tests
E. Antimicrobial susceptibility testing
Procedure
1. Prepare a suspension of the test organism by emulsifying several colony of the
organism in a small volume of nutrient broth
2. Much the turbidity of suspension with turbidity standard
3. With a sterile swab take sample from the suspension (squeeze the swab against the
side of the test tube to remove the excess fluid).
4. Spread the inoculums evenly over the Muller-Hinton agar plate with the swab.
5. Using a sterile forceps or needle, place the antimicrobial disc on the inoculated plate
6. Incubate the plate aerobically at 35-37oC for 18-24 hours
7. Read the test after checking that the bacterial growth is neither heavy nor light.
Measure the radius of the inhibition zone.
8. Interpret the reaction of the test organism to each antibiotics used as sensitive,
intermediate or resistance, using the standard.
Sensitive – zone of radius is wider or equal to the control.
Intermediate –zone of radius is more than three mm smaller than the control
Resistance – no zone of inhibition.
Annex-V     Information Sheet and Consent Form
Title: Bacterial profile of external ocular infections and their antimicrobial susceptibility
pattern in patients attending Borumeda Hospital North East Ethiopia, 2014.
Name of Investigator: Birtukan Shiferaw
Name of the Organization: University of Gondar Teaching Hospital
Introduction: You are invited to participate as a study participant in a research conducted.
Your participation is voluntarily. The research team includes principal investigator, data
collector and supervisor.
Purpose: -The main objective of the study is to collect information on external ocular
infection and susceptibility pattern for antimicrobial agents in and out patients.
Procedure to be carried out: In order to perform the indicated study at the Dessie town you
are invited to take part in this project. If you are willing to participate, you need to
understand the purpose of the study and your consent. The required clinical sample will be
collected by ophthalmic nurses and ocular surgeons who are currently working in the eye
unit. Then, you are requested to give your consent to the sample collector.
Risk associated with the study - You will not be at any physical or psychological risk and
should experience no discomfort resulting from the research procedures but during collection
of the pus you may feel some discomfort, this does not produce serious pain.
Benefits of the study - Based on the diagnosis result you will be treated accordingly.
Moreover, this study will have a great value on preventive measures in hospitals and in the
community. The results of this study have importance to treat the patients and to use as a
baseline for effective treatment in the absences of laboratory investigation.
Compensation for participation: You will not receive any payment for your participation in
this research study.
Confidentiality of your information- All information gathered from the study participant
will remain confidential. Your participation in this study is strictly anonymous. Personal
information will be treated confidentially and under no circumstances will it be transmitted to
any person or organization. The results of this study will be evaluated and summarized, and a
feedback of the results to the study participants will be given by principal investigator.
Voluntary participation - Your participation in the study is absolutely voluntary; no one is
obliged to take part. Refusal to participate will involve no penalty. Each study participant is
free to withdraw consent and discontinue participation in this study at any time.
Alternative option: - If you are not interested in this study you can leave it and you will do
in the main laboratory.
Person to contact: If you have any question you can contact the principal investigator and
you may ask at any time you want.
Principal investigator: Birtukan Shiferaw Cell phone +251913120877
E-mail: birtukan_sheferaw@yahoo.com
Consent form
Serial no------------ Name of health institution- Borumeda Hospital
Card no ---------------- Date--------------
I the undersigned study participant with ocular infection have been well informed about the
objective of the study entitled “Bacterial isolates and Antimicrobial susceptibility patterns of
external ocular infection in Borumeda Hospital in Dessie Town Northeast Ethiopia, 2014".
I am also told that all the information obtained at any course of the study is to be kept
confidential. Moreover I have also been well informed of my right to keep hold of, decline to
cooperate and drop out of the study if I want and none of my actions will have any bearing at
hospital access. I agreed voluntarily to provide the requested samples from me as well as my
child.
Name and signature of study participant_________________ Date_____________
Name and signature of investigator ________________Date_____________
Annex –VI Questionnaire (Amharic Version)
በበሽታ በተጠቃ ዐይን ዉስጥ የሚገኙ ባክቴሪያዎችን መለየትና የጸረባክቴሪያ መድሀኒት
የመቋቋም ባህሪያቸዉን ለማጥናት የተዘጋጀ መጠይቅ
የኮድቁጥር
የመታከሚያካርድቁጥር
ናሙናዉየተወሰደበተቀን
ምርመራ
ሀ. ማህበራዊና ኢኮኖማዊ መረጃ
SS]Á:- ›Á”Ç”Æ” ØÁo­‡” Ÿ’uv‹G< uGL Ÿ›T^à‡ ¨<eØ ¾}cÖ¨<” SMe
uT¡uw KØÁo lØ` ›”É SMc<” ulØ` éñ::
ተራቁጥር ጥያቄ ኮድ
1 እድሜ ?
2 ጾታ 1.ወ
2.ሴ
3 የትምህርት ደረጃ 1.ያልተማረ
2.የተማረ
4 መኖሪያ ቦታ 1. ገጠር
2. ከተማ
5 ስራ 1.የመንግስት ሰራተኛ
2.ገበሬ
3.ነጋዴ
4.የቤት እመቤት
5.የቀን ስራ
6.ሌላ ካሉ ይግለፁ
የአይን ሁኔታ
6 በየትኛዉ አይነት የአይን በሽታነዉ የተጠቃው ? 1.Blepharitis
2.Conjunctivitis
3.Keratitis
4.Hordeolum
5.Dacryocystit
6.Other infection, specify
የታካሚዉ ሁኔታ
7.
የአይን በሽታ መከላከያ መድሃኒት ተሰጥቶሀል/ሻል; 1. አዎ
2.አልተሰጠኝም
8. ፊትሽ/ህን በቀን ምን ያህል ጊዜ ትታጠቢያለሽ/ባለህ ? 1.በተደጋጋሚ
2. አልፎ አልፎ
3. በጣም በተደጋጋሚ
9. ንፁህ የመጠጥ ውሀ በአቅራቢያዎ አለ? 1.አዎ
2.የለም
10. የደም ዉስጥ የስኳር መጠን ተመርምረዉ ያዉቃሉ? 1. አዎ
2. አልተመረመርኩም
11. አዎ ካሉ 1.የስኳር በሸተኛ ነኝ
2. ጤነኛ ነኝ
12. ሌላ ተጨማሪ በሽታ አለብዎት? 1.አዎ
2.የለም
13.
አዎ ካሉ ምን ነበር?
14. አይን ላይ አደጋ ደርሶቦወት ያውቃል ? አዎ
አያውቅም
15. የአይን ቀዶ ጥገና ተሰርቶልሸ/ህያውቃል ? አዎ
አያውቅም
16. የአይን (contact lens) አድርገሽ /ህታውቂያለሽ/ህ? አዎ
አላውቅም
ለትብብርዎ እጅግ አድርገን እናመሰግናለን!!!
Annex VII የጥናቱ ማብራሪያ /Information Sheet/
የጥናቱ ርእስ፡
በበሽታ በተጠቃ ዐይን ዉስጥ የሚገኙ ባክቴሪያዎችን መለየትና የጸረባክቴሪያ መድሀኒት
የመቋቋም ባህሪያቸዉን በደሴ ከተማ በሚገኘው ቦሩሜዳ ሆስፒታል ለማዎቅ ነዉ፡፡
ጥናቱን የሚያካሂደዉ ሰዉ - ብርቱካን ሸፈራው
ለጥናቱ ተሳታፊዎች /ወላጆች/አሳዳጊዎች የሚሰጥ ማብራሪያ"
መግቢያ:- በመጀመሪያ እርስዎ በዚህ ጥናት ዉስጥ ተሳታፊ እንድሆኑ ሲጠየቁ ተሳታፊ
የሚሆኑት ፈቃደኛ ከሆኑ ብቻ ነዉ፡፡ ይህንን ጥናት የሚያካሂዱት ሰዎች የተዋቀሩት በዋና
ተመራማሪ፣ በጥናቱ ተቆጣጣሪዎች እና ናሙና ሰብሳቢዎች ነዉ፡፡
ዓላማ፡- የዚህ ጥናት ዋና አላማ በበሽታ በተጠቃ ዐይን ዉስጥ የሚገኙ ባክቴሪያዎችን
መለየትና የጸረባክቴሪያ መድሀኒት የመቋቋም ባህሪያቸዉን ለማወቅ ነዉ፡፡
ለጥናቱ የሚያስፈልግ ናሙና አወሳሰድ፡- ይህን ጥናት በደሴ ከተማ በሚገኘው ቦሩሜዳ
ሆስፒታል ለማካሄድ የእርስዎን ግለ-ታሪክ መጠየቅና ፈቃደኛነትዎን ማግኘት አስፈላጊ
ነዉ፡፡የጥናቱን አላማና ጥቅም በሚገባ ተረድተዉ ለመሳተፍ ፍላጎት ካለዎት፣
ሀ. ናሙና ለሚዎስደዉ ሰዉ ወይም ዋና ተመራማሪ ለሚጠይቀዎት ጥያቄ ተገቢዉን
መልስ ይሰጣሉ፡፡
ለ. ለምረመራ የሚያስፈልገዉን ናሙና ይሰጣሉ፡፡
ከጥናቱ ጋር ተያይዞ የሚመጣ ጉዳት - በዚህ ጥናት ዝርዝር አሰራር ሂደት ውስጥ አካላዊ
ወይም አእምራዊ ጉዳት አይኖርም፡፡ ነገርግን ናሙናዉ በሚወሰድበት ጊዜ መጠነኛ የሆነ
የህመም ስሜት ሊሰማወት ይችላል፡፡ይህ የህመም ስሜት ምንም አይነት ችግር
አያመጣብዎትም፡፡
ለተሳትፎ የሚሰጥ ማካካሻ ፡ምንም አይነት የካሳ ክፍያ የለዉም፡፡
የጥናቱ ጥቅም፡ የምርምሩ ዉጤት በዐይን ዉስጥ የሚገኙ አደገኛ የሆኑ ባክቴሪያዎችን
በማጥናት የመፈወስ አቅምያላቸዉን መድሀኒቶችን ለማወቅ ያስችላል፡፡ እንደዚሁም
በእርስዎ ዐይን ላይ እነዚህ ባክቴሪያዎች ከተገኙ አስፈላጊዉ መድሀኒት እንዲያገኙ ለሃኪሙ
ይነገርሎታል፡፡በተጨማሪም ይህ ጥናት የመከላለል ስራ በሆሰፒታል እና በህብረተሰቡ ዘንድ
እንዲኖር ያግዛል፡፡እንደዚሁም ደግሞ የላቦራቶሪ አገልግሎት በሌለበት ጤናተቋም ትክክለኛ
መድሃኒት ለመስጠት እንደአመላካች ሆኖ ያገለግላል፡፡
የመረጃሚ ስጢራዊነት -ሁሉም ከተሳታፊዎች የሚሰበሰቡ መረጃዎች በሚስጢር የሚያዙ
እና የሚጠበቁ ይሆናሉ፡፡በማንኛውም ምክኒያት ተሳታፊዎች እነማን መሆናቸውን የሚያሳይ
በመጠይቁ ይሁን በሌላነገር አይኖርም፡፡የተሰበሰቡ መረጃዎች ለሶስተኛ ወገን ተላልፎ
አይሰጥም፡፡በተጨማሪም ውጤቱ የሚለካዉ ይሁን ተሰብስቦ የሚያዘው በዋና አጥኚ ነው፡፡
በፍቃደኝነት ላይ የተመሰር ተተሳትፎ - በጥናቱ ለመሳተፍ ሙሉ በሙሉ በተሳታፊዎች
ፍቃደኝነት የተመሰረት ነው፡፡ከዚህ በተጨማሪ የተሳታፊዎች መሳተፍ እና አለመሳተፍ
በራሳቸዉ ብቻ የሚወሰን እንጂ የማንም ጣልቃ ገብነት አይኖረውም፡፡እንደዚሁም ደግሞ
ተሳታፊዎች በማንኛውም ግዜያ ለምንም ቅጣት ጥናቱን ማቋረጥ ይችላሉ፡፡
አማራጭ -ማንኛዉም በጥናቱ መሣተፍ ፍላጎት የሌለዉ ከዋናዉ በዞኑ በሚገኘው ላቦራቶሪ
ሄዶ ማሰራት ይችላል፡፡
ተጠሪ - በማንኛዉም ጊዜ መጠቅ የሚፈልጉት ጥያቄ ካለ መጠየቅ ይችላሉ፡፡
የተመራማሪአድራሻ :
ስልክ: +251913120877
ኢ-ሜል: birtukan_sheferaw@yahoo.com
የስምምነት ዉል
ቀን----------------
ተራቁጥር---------------------የሚታከምበት ክፍል-------------------------- የካርድ ቁጥር----------
--
እኔ ከዚህ በታች ስሜ የተጠቀሰዉና የፈረምኩት የጥናቱ ተሳታፊ በዐይን ዉስጥ የሚገኙ
ባክቴሪያዎችን መለየትና የጸረባክቴሪያ መድሀኒት የመቋቋም ባህሪያቸዉን በደሴ ከተማ
በሚገኘው ቦሩሜዳ ሆስፒታል ለማዎቅ የሚደረገዉን ጥናት አላማና ጥቅም በሚባ
ተረድቻለሁ፡፡ ጥናቱ ላይ መሳተፍም ሆነ አለመሳተፍ በራሴ ፍቃድ የሚወሰን መሆኑም
ተገልጾልኛል፡፡ በተጨማሪም ከጥናቱ ባልሳተፍም ሆነአቋርጨ ብወጣ ጤናተቋሙ በማገኘዉ
የህክምና አገልግሎት ምንም አይነት ችግር እንደማይደርስብኝ ተነግሮኛል፡፡
በመሆኑም ከእኔም ሆነ ከልጄ አይን ናሙና ተጠረጎ መዉሰድ አስፈላጊ መሆኑን
ስለተስማማሁበት ለመስጠት ሙሉ ፈቃደኛ መሆኔን በፊርማዬ እገልጻለሁ፡፡
የተሳታፊ ስምና ፊርማ _______________ቀን ____________
የተመራማሪ ስምና ፈርማ ______________ ቀን ________

